Examination of claudin-1 expression in patients undergoing liver transplantation owing to hepatitis C virus cirrhosis

Transplant Proc. 2011 May;43(4):1267-71. doi: 10.1016/j.transproceed.2011.03.066.

Abstract

The cell adhesion molecule claudin-1 (CLDN-1) is a well known co-factor for the cell entry of hepatitis C virus (HCV). We examined 24 hepatic biopsies from liver transplant patients. Reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry were performed according to standard procedures. RT-PCR results were shown as relative expression (ΔCT) with beta-actin as the reference gene. Immunohistochemistry results are shown by morphometry. The CLDN-1 mRNS expression rate was significantly lower when the patient displayed favorably with an unsatisfactory to antiviral therapy 0.756 ± 0.249 versus 1.304 ± 0.28 (P=.012). There was also a strong positive correlation between CLDN-1 protein expression and liver fibrosis (Pearson correlation coefficients: r=0.476; P=.034).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use
  • Biopsy
  • Claudin-1
  • Female
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / genetics
  • Hepatitis C, Chronic / metabolism
  • Humans
  • Hungary
  • Immunohistochemistry
  • Liver / metabolism
  • Liver / surgery*
  • Liver / virology
  • Liver Cirrhosis / genetics
  • Liver Cirrhosis / metabolism
  • Liver Cirrhosis / surgery*
  • Liver Cirrhosis / virology
  • Liver Transplantation*
  • Male
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Middle Aged
  • RNA, Messenger / metabolism
  • Recurrence
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Treatment Outcome

Substances

  • Antiviral Agents
  • CLDN1 protein, human
  • Claudin-1
  • Membrane Proteins
  • RNA, Messenger